CYP1A2 and Caffeine: What rs762551 Can and Can't Tell You

Caffeine Metabolism and CYP1A2: What One Marker Can and Can't Tell You

TL;DR: The CYP1A2 gene influences how quickly your liver breaks down caffeine. At the most studied marker, rs762551, about 41% of people in the 1000 Genomes Project carry AA, a genotype associated with higher CYP1A2 inducibility; the rest carry AC or CC. Studies often call AA carriers "fast" and C carriers "slow" metabolizers, but one marker does not measure how fast your own body clears caffeine. Research suggests the genotype may modify how coffee relates to cardiovascular risk, kidney function, and exercise performance, with mixed results.

Disclaimer: This article is for educational purposes. It does not constitute medical advice. Consult a healthcare professional for personalized guidance.

In this article

• What is CYP1A2 and why does it matter?
• Fast vs slow caffeine metabolizers
• The rs762551 variant explained
• Caffeine, cardiovascular risk, and CYP1A2
• What the evidence supports today
• Frequently asked questions

Your co-worker drinks three espressos after lunch and sleeps soundly at 10 PM. You have a single cup at noon and lie awake until midnight. Part of the difference is how fast the liver clears caffeine. That varies between people for many reasons, and a variant in the CYP1A2 gene is one of the factors studied.

More than 95% of caffeine metabolism occurs through a single enzyme: cytochrome P450 1A2, encoded by the CYP1A2 gene. This makes caffeine metabolism one of the best-studied examples in nutrigenomics.

What Is CYP1A2 and Why Does It Matter for Coffee Drinkers?

CYP1A2: a liver enzyme in the cytochrome P450 family responsible for metabolizing more than 95% of ingested caffeine, as well as several pharmaceutical drugs. The most studied SNP in the gene is rs762551.

The CYP1A2 enzyme sits in the liver and breaks down caffeine into three primary metabolites: paraxanthine, theobromine, and theophylline. How quickly this happens varies between people; rs762551 is one of several factors studied. The AA genotype has been associated with higher enzyme inducibility — meaning activity rises more in response to inducers such as smoking. In the original study, the difference was seen in smokers but not in non-smokers (Sachse et al., Br J Clin Pharmacol, 1999).

Smoking, some medications and pregnancy also change CYP1A2 activity (see below). The marker is one factor among these, not the whole story.

Fast vs Slow Caffeine Metabolizers

The studies below call AA carriers "fast metabolizers" and carriers of the C allele (AC or CC) "slow metabolizers". Those are the studies' labels for genotype groups, not a measurement of anyone's own caffeine clearance. The rs762551 variant creates three genotypes:

These labels describe groups in studies, not a measured caffeine clearance for any one person. Smoking, pregnancy, oral contraceptives and other factors (below) can shift CYP1A2 activity more than this marker does.

How you respond to an afternoon coffee is a practical guide to your own tolerance. A DNA analysis can tell you your rs762551 genotype, but not a definitive answer about how fast you clear caffeine.

What the Research Says About Coffee and Your CYP1A2 Genotype

Research on rs762551 genotype groups extends beyond sleep. Several lines of research have examined whether genotype changes coffee's effects on cardiovascular health and kidney function.

Cardiovascular Risk: A Mixed Picture

The most-cited study on CYP1A2 and heart health is the 2006 Cornelis et al. paper in JAMA, which analyzed 2,014 individuals who had experienced a first non-fatal myocardial infarction (heart attack) against 2,014 matched controls. In C-allele carriers (the study's "slow metabolizers"), coffee was associated with higher odds of non-fatal MI: OR 1.36 at 2–3 cups a day and 1.64 at 4 or more, with higher estimates in people under 59. AA carriers showed no increase at any consumption level (Cornelis et al., JAMA, 2006).

However, the story has become more complex. A 2019 prospective analysis of 347,077 individuals in the UK Biobank found no significant interaction between CYP1A2 genotype and coffee intake for overall cardiovascular disease risk (Zhou & Hypponen, Am J Clin Nutr, 2019). The discrepancy likely reflects differences in study design: the original was a case-control study (prone to selection bias), while the UK Biobank analysis was prospective and far larger.

The honest summary: one case-control study found higher risk with heavy coffee intake in C-allele carriers, and a much larger prospective study did not confirm it. The evidence is not definitive and does not support genotype-specific limits.

Kidney Function

A 2023 Italian cohort study followed 604 young adults with stage 1 hypertension. Among C-allele carriers (AC or CC), drinking more than three cups of coffee a day was associated with higher risks of albuminuria (protein in urine), hyperfiltration, and hypertension. No such association was seen in the AA group (Mahdavi et al., JAMA Netw Open, 2023).

This is an association in one study of a specific group. It has not been shown to apply to other populations.

CYP1A2 and Athletic Performance

The question of whether caffeine's well-documented ergogenic (performance-enhancing) effects depend on CYP1A2 genotype has generated significant research interest — and significant debate.

A 2024 systematic review and meta-analysis pooling data from 13 studies found genotype-dependent effects: fast metabolizers (AA) showed meaningful performance improvement with caffeine supplementation (standardized mean difference of 0.30), while slow metabolizers with the AC genotype showed modest improvement (0.16). Carriers of the CC genotype actually showed worsened performance with caffeine (SMD = -0.22). However, once studies with reported conflicts of interest were excluded, no influence of genotype was seen, and the authors advise caution (Barreto et al., Med Sci Sports Exerc, 2024).

In cycling-specific research, caffeine at doses of 2 and 4 mg/kg improved 10-km time trial performance — but only in participants with the AA genotype. Those with the CC genotype saw no benefit at the lower dose and decreased performance at the higher dose. For resistance training, a 2024 study in trained women found that the fast metabolizer group completed significantly more repetitions to failure than the slow group after caffeine ingestion (PMC, 2024).

These are group averages from small trials: in some studies the C-allele group gained less from pre-workout caffeine than the AA group, and the evidence is not consistent enough to set anyone's own dose.

That said, the research is not fully settled. Some studies find no genotype interaction, and the field acknowledges that more mechanistic research is needed before genotype-based caffeine dosing becomes a clinical recommendation.

What Else Affects Your Caffeine Metabolism

CYP1A2 genotype is the primary genetic factor, but it is not the only variable. Several environmental and physiological factors modify caffeine metabolism speed:

Smoking is a potent inducer of CYP1A2. Regular smokers metabolize caffeine roughly 50-60% faster than non-smokers, which is why some smokers can consume large quantities of coffee with minimal apparent effect.

Pregnancy substantially inhibits CYP1A2 activity, particularly in the second and third trimesters. Caffeine half-life can double or triple during pregnancy, which is one reason clinical guidelines recommend limiting intake to 200 mg per day (roughly one 12-ounce cup of coffee).

Oral contraceptives inhibit CYP1A2 activity, slowing caffeine metabolism. Women taking hormonal contraceptives may notice increased sensitivity to caffeine compared to their baseline.

Grapefruit juice inhibits CYP1A2, slowing caffeine clearance by approximately 23% and increasing its half-life by 31%. This is the same enzyme-inhibition mechanism that creates grapefruit interactions with numerous medications.

Cruciferous vegetables (broccoli, Brussels sprouts, cauliflower) induce CYP1A2 activity when consumed regularly. This means a diet rich in these vegetables may slightly increase your caffeine metabolism rate.

Age and liver function naturally affect CYP1A2 activity. Enzyme activity tends to decline with age, meaning caffeine sensitivity may increase over time regardless of genotype.

What the Evidence Supports Today

There are no validated genotype-specific limits for caffeine. The safety guidance that applies to everyone comes from the European Food Safety Authority: for healthy adults, up to 400 mg a day (and single doses up to 200 mg) raise no safety concerns, and during pregnancy up to 200 mg a day (EFSA, 2015). An rs762551 result does not change those numbers, and it is not a reason to set your own limit or bedtime cut-off by genotype. If you have heart disease, high blood pressure or are pregnant, decisions about caffeine belong with your clinician.

DeepDNA's perspective: CYP1A2 is a good example of why one marker needs care: in the original study (Sachse 1999), the inducibility effect of rs762551 was seen in smokers, not in non-smokers, and large prospective studies have not confirmed every association. A genotype is a biological data point about an everyday habit, not a measurement of it. The challenge for the field is ensuring that the nuance in the evidence (particularly around cardiovascular risk) is communicated honestly rather than oversimplified into "good gene" and "bad gene" categories.

An rs762551 result is one data point about a group-level association, not a verdict on your coffee habit.

Your genome describes probabilities, not certainties. Your CYP1A2 variant does not diagnose you, and it is not a reason to set your own caffeine limit.

Frequently Asked Questions

How do I find out my CYP1A2 genotype?

Several direct-to-consumer genetic testing services report CYP1A2 rs762551 status, including those that analyze raw DNA data from 23andMe or AncestryDNA. The variant is included in most standard SNP genotyping arrays. DeepDNA does not assign metabolizer status: it is an API for developers and AI agents, not a consumer service. Educational information only — not a medical diagnosis.

What does rs762551 tell me about caffeine?

The rs762551 single nucleotide polymorphism is the most studied marker in CYP1A2. The AA genotype has been associated with higher enzyme inducibility, an effect seen in smokers in the original study (Sachse 1999). Your genotype at this position (AA, AC, or CC) is one input among several; it does not tell you your own caffeine half-life. This information is educational; clinical decisions should involve a qualified healthcare professional.

Does carrying the C allele at rs762551 mean coffee is bad for me?

Not necessarily. A single marker does not measure how fast you clear caffeine. The research suggesting higher cardiovascular risk comes from one case-control study, where the association in the C-allele group appeared from 2–3 cups a day, and later studies have not confirmed every association. The general EFSA guidance applies to everyone. Discuss any cardiovascular concerns with your doctor.

Can I change my caffeine metabolism speed?

You cannot change your CYP1A2 genotype, but environmental factors do modify enzyme activity. Cruciferous vegetables and regular physical activity can modestly induce CYP1A2, while oral contraceptives and grapefruit inhibit it. Educational context — not dietary prescription.

What are the three CYP1A2 genotypes (AA, AC, CC)?

The rs762551 variant creates three genotypes: AA (about 41% of people in the 1000 Genomes Project, associated with higher CYP1A2 inducibility), AC (about 44%), and CC (about 15%). Studies often call AA carriers "fast" and AC/CC carriers "slow" metabolizers; these are group labels, not a measurement of your own caffeine clearance. These are population averages; individual responses vary.

Does CYP1A2 genotype change caffeine's effect on exercise?

Some studies report that the performance benefit of caffeine differs by CYP1A2 genotype: in some trials the AA group improved at 2-4 mg/kg doses while the C-allele group gained less or none. Results are not consistent across studies. This finding, published in studies including Guest et al. (2018, Medicine & Science in Sports & Exercise), remains an active area of research. Consult a sports medicine professional before using caffeine as a performance aid.

Caffeine is one of the best-studied examples in nutrigenomics. Your rs762551 genotype is one input among several, alongside smoking, medications, pregnancy and how coffee actually affects you.

For a fuller picture, consider how caffeine interacts with your COMT dopamine metabolism and sleep chronotype genetics.

DeepDNA is an API for developers and AI agents, not a consumer service: there is no report to buy. Its knowledge records — genes, variants and drug–gene pairs, each cited — are live, free and need no key, through the MCP server or the API. DeepDNA does not parse DNA files on its servers; to read a raw DNA file, the free local package deepdna-mcp reads it on your own computer and sends DeepDNA nothing from it.

This article was created with AI assistance and reviewed by the DeepDNA editorial team.